Your browser doesn't support javascript.
loading
Regulation of ALT-associated homology-directed repair by polyADP-ribosylation.
Hoang, Song My; Kaminski, Nicole; Bhargava, Ragini; Barroso-González, Jonathan; Lynskey, Michelle L; García-Expósito, Laura; Roncaioli, Justin L; Wondisford, Anne R; Wallace, Callen T; Watkins, Simon C; James, Dominic I; Waddell, Ian D; Ogilvie, Donald; Smith, Kate M; da Veiga Leprevost, Felipe; Mellacharevu, Dattatreya; Nesvizhskii, Alexey I; Li, Jianfeng; Ray-Gallet, Dominique; Sobol, Robert W; Almouzni, Genevieve; O'Sullivan, Roderick J.
Afiliación
  • Hoang SM; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Kaminski N; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Bhargava R; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Barroso-González J; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Lynskey ML; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • García-Expósito L; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Roncaioli JL; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Wondisford AR; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Wallace CT; Department of Cell Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Watkins SC; Department of Cell Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • James DI; Drug Discovery Unit, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, Macclesfield, UK.
  • Waddell ID; Drug Discovery Unit, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, Macclesfield, UK.
  • Ogilvie D; Drug Discovery Unit, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, Macclesfield, UK.
  • Smith KM; Drug Discovery Unit, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, Macclesfield, UK.
  • da Veiga Leprevost F; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Mellacharevu D; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Nesvizhskii AI; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Li J; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
  • Ray-Gallet D; Department of Pharmacology and the Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
  • Sobol RW; Institut Curie, PSL Research University, CNRS, Sorbonne Université, Nuclear Dynamics Unit, Equipe Labellisée, Ligue contre le Cancer, Paris, France.
  • Almouzni G; Department of Pharmacology and the Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
  • O'Sullivan RJ; Institut Curie, PSL Research University, CNRS, Sorbonne Université, Nuclear Dynamics Unit, Equipe Labellisée, Ligue contre le Cancer, Paris, France.
Nat Struct Mol Biol ; 27(12): 1152-1164, 2020 12.
Article en En | MEDLINE | ID: mdl-33046907
ABSTRACT
The synthesis of poly(ADP-ribose) (PAR) reconfigures the local chromatin environment and recruits DNA-repair complexes to damaged chromatin. PAR degradation by poly(ADP-ribose) glycohydrolase (PARG) is essential for progression and completion of DNA repair. Here, we show that inhibition of PARG disrupts homology-directed repair (HDR) mechanisms that underpin alternative lengthening of telomeres (ALT). Proteomic analyses uncover a new role for poly(ADP-ribosyl)ation (PARylation) in regulating the chromatin-assembly factor HIRA in ALT cancer cells. We show that HIRA is enriched at telomeres during the G2 phase and is required for histone H3.3 deposition and telomere DNA synthesis. Depletion of HIRA elicits systemic death of ALT cancer cells that is mitigated by re-expression of ATRX, a protein that is frequently inactivated in ALT tumors. We propose that PARylation enables HIRA to fulfill its essential role in the adaptive response to ATRX deficiency that pervades ALT cancers.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN de Neoplasias / Regulación Neoplásica de la Expresión Génica / Procesamiento Proteico-Postraduccional / Telómero / Poli(ADP-Ribosa) Polimerasas / Reparación del ADN por Recombinación / Glicósido Hidrolasas Tipo de estudio: Risk_factors_studies Idioma: En Revista: Nat Struct Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN de Neoplasias / Regulación Neoplásica de la Expresión Génica / Procesamiento Proteico-Postraduccional / Telómero / Poli(ADP-Ribosa) Polimerasas / Reparación del ADN por Recombinación / Glicósido Hidrolasas Tipo de estudio: Risk_factors_studies Idioma: En Revista: Nat Struct Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
...